EUVIMEDEUVIMED entdecken
Leitlinie

2026 Guidelines of the Working Group of the Polish Society of Laboratory Diagnostics for Hemostasis Diagnostics and the College of Laboratory Medicine on the basic panel of hemostasis tests as part of the organization of laboratory hemostasis diagnostics – interpretation of results, pitfalls, and clinical application in diagnostic practice

Jacek Golański, Anna Raszeja-Specht, Anna Michno, Karolina Turkiewicz, Małgorzata Rusak, Mirosława Pietruczuk, Urszula Rychlik

Diagnostyka Laboratoryjna · 30.07.2026 · 62 (3) · 121-143

DOI: 10.5604/01.3001.0055.8633 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Diagnostyka Laboratoryjna, erschienen am 30.07.2026. Verfasst von Jacek Golański und 6 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The basic haemostasis testing panel is the principal first-line laboratory assessment in patients with bleeding, suspected multifactorial coagulopathy, venous thromboembolism, disseminated intravascular coagulation, liver disease, complications of anticoagulant therapy, and emergency conditions requiring rapid evaluation of bleeding or thrombotic risk. Its core components include platelet count, prothrombin time, usually reported together with the international normalized ratio, activated partial thromboplastin time, fibrinogen measured using the Clauss method, and D-dimer concentration. In many laboratories, thrombin time provides complementary information, while reptilase time may be useful in selected clinical situations.

The basic panel should not be regarded solely as a set of screening assays. In a modern model of laboratory haemostasis diagnostics, it functions as a local decision-making node. It enables rapid identification of abnormalities, assessment of clinical urgency, recognition of preanalytical errors, planning of further investigations, and determination of whether the patient or the sample should be referred to a specialist laboratory.

The diagnostic value of the panel depends not only on analytical performance, but also on the organization of the entire total testing process. This includes sample collection and transport, preparation of platelet-poor plasma, time from collection to analysis, drug-related interference, quality control, reporting of results, use of interpretative comments, and clearly defined pathways for further testing. The greatest diagnostic value is achieved through integrated interpretation of all parameters rather than isolated assessment of individual results.

Each result pattern should be evaluated with consideration of sample quality, the blood-to-citrate ratio, haematocrit, plasma preparation, time to analysis, anticoagulant and antiplatelet therapy, and the limitations of the specific analyser–reagent system. Particular attention should be paid to differentiating coagulation factor deficiency from the presence of an inhibitor, which often requires a plasma mixing test, and to distinguishing genuine haemostatic abnormalities from those caused by preanalytical errors, heparin contamination, direct oral anticoagulant interference, or inappropriate interpretation of D-dimer concentration.

Zitieren

APA

Golański, J., Raszeja-Specht, A., Michno, A., Turkiewicz, K., Rusak, M., Pietruczuk, M., & Rychlik, U. (2026). 2026 Guidelines of the Working Group of the Polish Society of Laboratory Diagnostics for Hemostasis Diagnostics and the College of Laboratory Medicine on the basic panel of hemostasis tests as part of the organization of laboratory hemostasis diagnostics – interpretation of results, pitfalls, and clinical application in diagnostic practice. Diagnostyka Laboratoryjna, 62(3), 121-143. https://doi.org/10.5604/01.3001.0055.8633

Vancouver

Golański J, Raszeja-Specht A, Michno A, Turkiewicz K, Rusak M, Pietruczuk M, et al. 2026 Guidelines of the Working Group of the Polish Society of Laboratory Diagnostics for Hemostasis Diagnostics and the College of Laboratory Medicine on the basic panel of hemostasis tests as part of the organization of laboratory hemostasis diagnostics – interpretation of results, pitfalls, and clinical application in diagnostic practice. Diagnostyka Laboratoryjna. 2026;62(3):121-143. doi:10.5604/01.3001.0055.8633

BibTeX
@article{Golaski2026,
  author = {Golański, Jacek and Raszeja-Specht, Anna and Michno, Anna and Turkiewicz, Karolina and Rusak, Małgorzata and Pietruczuk, Mirosława and Rychlik, Urszula},
  title = {2026 Guidelines of the Working Group of the Polish Society of Laboratory Diagnostics for Hemostasis Diagnostics and the College of Laboratory Medicine on the basic panel of hemostasis tests as part of the organization of laboratory hemostasis diagnostics – interpretation of results, pitfalls, and clinical application in diagnostic practice},
  journal = {Diagnostyka Laboratoryjna},
  year = {2026},
  volume = {62},
  number = {3},
  pages = {121--143},
  doi = {10.5604/01.3001.0055.8633}
}
Kostenlos starten →